ZBH · News · 20260804N

Market Demand Trends

ZIMMER BIOMET HOLDINGS, INC. · 2026-08-04 · Importance 31 · Surprise 32

Zimmer Biomet reported 4.0% organic constant-currency sales growth in the second quarter, with implant demand described as strong. Hip sales were a primary growth driver, particularly in the United States, while knee performance remained weaker. Management cited a healthy orthopedic market and expected weighted-average market growth of 5% to 6% by 2030.

Key facts

• Zimmer Biomet's stock fell 1.21% on Tuesday, closing at $95.81, and was trading 11.52% below its 52-week high source